Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition
- 31 December 2010
- journal article
- Published by Elsevier BV in Experimental and Molecular Pathology
- Vol. 89 (3), 209-216
- https://doi.org/10.1016/j.yexmp.2010.09.001
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The many facets of the Wilms' tumour gene, WT1Human Molecular Genetics, 2006
- Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic ApproachMolecular & Cellular Proteomics, 2006
- Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progressionInternational Journal of Colorectal Disease, 2005
- Mechanism of the SDS-resistant Synaptotagmin Clustering Mediated by the Cysteine Cluster at the Interface between the Transmembrane and Spacer DomainsOnline Journal of Public Health Informatics, 2001
- Characterization of KIAA1427 protein as an atypical synaptotagmin (Syt XIII)Biochemical Journal, 2001
- E-cadherin Is a WT1 Target GeneOnline Journal of Public Health Informatics, 2000
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature, 2000
- WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblastsOncogene, 1999
- Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell linesMolecular Carcinogenesis, 1997
- Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell line by the p11.2–p12 region of human chromosome 11Molecular Carcinogenesis, 1995